Dioxolane derivates for the treatment of cancer

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 405/04 (2006.01) A61K 31/513 (2006.01) A61K 31/52 (2006.01) C07D 473/28 (2006.01) C07D 473/30 (2006.01) C07D 473/34 (2006.01) C07D 473/40 (2006.01)

Patent

CA 2632280

This invention relates to certain unsaturated fatty acid derivatives of therapeutically active 1,3-dioxolane nucleoside analogues and to pharmaceutical formulations containing them. The said derivatives are referred to as "Compounds of formula (I)" herein. Compounds of formula (I) can be used in the treatment of a cancerous disease. Treatment of both solid tumours and haematological cancers such as leukaemias, lymphomas and multiple myelomas are included.

La présente invention concerne certains dérivés d'acides gras insaturés d'analogues thérapeutiquement actifs de nucléosides de type 1,3-dioxolanne, ainsi que des formules pharmaceutiques les incluant. Lesdits dérivés sont appelés « Composés de formule (I) » dans la présente invention. Les composés de formule (I) peuvent être employés dans le traitement d'une maladie cancéreuse. L~invention inclut le traitement de tumeurs solides et de cancers hématologiques tels que les leucémies, les lymphomes et les myélomes multiples.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dioxolane derivates for the treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dioxolane derivates for the treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dioxolane derivates for the treatment of cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1993968

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.